Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer

Pancreatic cancer remains a diagnosis of poor prognosis with a median survival time of four-six months in patients with advanced stage of the disease. Although, with the development of novel chemotherapy agents some patients are able to live a little longer if they respond to therapy. However, long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzukida, Jillian, Kaley, Kristin, Raza, Azra, Saif, Muhammad W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981410/
https://www.ncbi.nlm.nih.gov/pubmed/27555985
http://dx.doi.org/10.7759/cureus.687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981410/
https://www.ncbi.nlm.nih.gov/pubmed/27555985
http://dx.doi.org/10.7759/cureus.687

Ejemplares similares